학술논문
EE394 Cost-Effectiveness of Alpelisib Plus Fulvestrant for the Treatment of Postmenopausal Women With PIK3CA Mutant, HR+/HER2- Advanced Breast Cancer in Turkey
Document Type
Abstract
Author
Source
In Value in Health December 2022 25(12) Supplement:S133-S133
Subject
Language
ISSN
1098-3015